(KEH-puh-vants) A form of keratinocyte growth factor (KGF) that is made in the laboratory. KGF stimulates the growth of cells that line the surface of the mouth and intestinal tract. Kepivance is used to prevent and treat oral mucositis (mouth sores) caused by high-dose chemotherapy and radiation therapy in leukemia and lymphoma. It is also being studied in the prevention and treatment of oral mucositis and dysphagia (difficulty swallowing) in other types of cancer. Kepivance is a type of recombinant human keratinocyte growth factor. Also called palifermin.
- Browse Related Terms: arsenic, autologous expanded mesenchymal stem cells OTI-010, conventional treatment, Gelclair, Gonzalez regimen, Kepivance, moxibustion, palifermin, polyvinylpyrrolidone-sodium hyaluronate gel, RK-0202, Stromagen, toxicology, ultrasound energy